Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 mai 2016 07h30 HE | Source: OpGen, Inc.

OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities

Consortium of Washington, D.C. Health Organizations and OpGen test over 1,000 patient samples for antibiotic resistant bacteria OpGen’s Acuitas® detection technology provides surveillance to put...
02 mai 2016 12h22 HE | Source: OpGen, Inc.

OpGen Appoints Harry J. D'Andrea to Board of Directors

GAITHERSBURG, Md., May 02, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announces...
11 avr. 2016 07h30 HE | Source: OpGen, Inc.

New Study Data Show OpGen’s QuickFISH® Blood Culture Pathogen ID Tests to be Rapid and Cost-Effective, with Utility to Inform Antimicrobial Stewardship Decisions

GAITHERSBURG, Md., April 11, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, today...
30 mars 2016 07h30 HE | Source: OpGen, Inc.

OpGen Announces 2015 Fourth Quarter and Full Year Financial Results

Conference call begins at 10:00 a.m. Eastern time today GAITHERSBURG, Md., March 30, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics...
21 mars 2016 07h30 HE | Source: OpGen, Inc.

OpGen Announces New Members to its Clinical Advisory Board

GAITHERSBURG, Md., March 21, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announced...
16 mars 2016 11h08 HE | Source: OpGen, Inc.

OpGen, Inc. Announces Timing for 2015 Fourth Quarter and Year End Financial Results and Conference Call

GAITHERSBURG, Md., March 16, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, today...
03 févr. 2016 08h00 HE | Source: OpGen, Inc.

OpGen to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference

GAITHERSBURG, Md., Feb. 03, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announces...
13 janv. 2016 16h00 HE | Source: OpGen, Inc.

OpGen, Inc., to Present at Noble Financial Capital Markets’ 12th Annual Investor Conference

GAITHERSBURG, Md., Jan. 13, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a molecular diagnostics and bioinformatics company helping to guide antibiotic therapy and to assist healthcare...
17 déc. 2015 08h30 HE | Source: OpGen, Inc.

OpGen's QuickFISH Rapid Pathogen ID Test Demonstrates Clinical Utility and Cost Effectiveness in Community Hospital’s Antimicrobial Stewardship Program

GAITHERSBURG, Md., Dec. 17, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), a molecular diagnostics and bioinformatics company helping to guide antibiotic therapy and to assist healthcare...
18 nov. 2015 08h30 HE | Source: OpGen, Inc.

District of Columbia Hospital Association Chooses OpGen to Create Citywide Effort to Track Multidrug-Resistant Bacteria

GAITHERSBURG, Md. and WASHINGTON, Nov. 18, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) and the District of Columbia Hospital Association (DCHA) today announced that Washington DC’s public...

Page précédente